The contents of this program is subject to changes SYMPOSIA   S01 Dual Pathology and Tobacco Chair: V. García-Vicent (Spain) Speakers: Why do individuals with psychiatric symtomathology smoke more tobacco? F. Javier Ayesta (Spain) Tobacco abuse in psicotic patients C. Pinet (España) Bipolar disorder and tobacco abuse M. Gurpegui (Spain) S02 Trends of Neuroscience in Dual Pathology Chair: E. Baca-García (Spain) Speakers: Alcoholism and bipolar disorder; functional results from brain images L. Sher (USA) Bipolar disorder and alcoholism in adolescents: an evolutive perspective J. J. Carballo (Spain) From Dual Pathology to Endophenotypes. A specific example of suicidal behaviour P. Courtet (France) Tobacco use and Schizophrenia J. De Leon (USA) S03 Neurobiological and Epidemiological evidence of a casual relation between cannabis and psychosis Chair: L. A. Núñez-Domínguez (Spain) Speakers: Neurobiological and Epidemiological evidence of a casual relationship between cannabis and psychosis L. A. Núñez-Domínguez (Spain) Endocannabinoid and psychosis system: Two faces on the same coin E. Fernández-Espejo (Spain) Animal models for the evaluation of psychotic –like symptoms and other comorbid neuropsychiatric alterations associated with neurodevelopmental insults: Interactions with the endocannabinoid system M. P. Viveros (Spain) F. Rodríguez-Fonseca (Spain) S04 Neurobiological Mechanisms implicated with the interrelationship between the intake of Cannabis and other drugs Chaires: J. A. Ramos-Atance (Spain) F. Arias-Horcajadas (Spain) Speakers: Neurobiology of the interrelationship between the intake of cannabis and alcohol J. Fernandez-Ruiz (Spain) Neurobiological mechanisms of the interrelationship between cocaine and cannabis intake E. Ambrosio (Spain) Neurobiology of Extasis intake. Role of endogenous cannabinoid system I. Colado (Spain) S05 Psychopathology associated to cannabis intake Chair: F. Arias-Horcajadas (Spain) Speakers: Mood Disorders and anxiety related to cannabis intake E. Ochoa-Mangado (Spain) Psychosis and cannabis intake L. A. Nuñez-Dominguez (Spain) Presenting Clinical cases associated with cannabis intake A. Madoz-Gúrpide (Spain) Presenting Clinical cases associated with cannabis intake M. García-Nieto (Spain) S06 A New Path in Schizophrenia and Dual Pathology        (Satelite symposium organized by Bristol-Myers Otsuka) Chair:                              J.Bobes (Spain) Speakers:                        Tripment of alcoholism in serious mental illness                                        J. Bobes (Spain)                                              Impact of physical health in dual pathology                                        M. Bernardo (Spain)                                                                               Management of serious mental illnesses: Schizophrenia                                        J. Sanjuan (Spain)   S07 Personality Disorders and Addictions Chair: L. Peris (Spain) Speakers: Impulsivity, Addiction and Personality Disorders. Are we referring to Cluster B? L. Peris (Spain) Comorbidity between Personality Disorders and Addiction. Beyond Cluster B M. A. González-Torres (Spain) Borderline Personality Disorder and opiate use N. Szerman (Spain) Discusor: J. Didia-Attas (Argentina) S08 Models of treatment in Dual Pathology: From a clinical experience Chair: J. Martínez-Raga (Spain) Speakers: Dual Pathology: From theory to clinical practice L. San Molina (Spain) Model of treatment in U.K for patients with Dual Pathology A. M. Almaraz-Serrano (United Kingdom) Approach into Dual Pathology Networks J. Didia-Attas (Argentina) Psychiatric pathology and drug abuse: How to identify and treat it. An experience of the Bizia Bayona Drug abuse center J. P. Daulouede (France) S09 Epigenetics and Impulsiveness in Dual Pathology Chair: M. A. Jimenez-Arriero (Spain) Speakers: Genotypes and Phenotypes associated to interactive and addictive impulsivity J. Hoenicka (Spain) Clinical implications of impulsivity trends in addictive behaviors G. Ponce-Alfaro (Spain) Pharmacological management of comorbidity in impulsive Dual Pathology I. Martinez-Gras (Spain) The impulsivity as a resource in Dual Pathology coping M. Iribarren (Spain)   S10 Alcoholism and Dual Pathology in clinical consultancy and research Chair: J. Solé (Spain) Speakers: Neurobiological aspects of substance intake and the psychosis P. McKenna (United Kingdom) Dual Pathology in Spain: Implemented answers J. Valls (Spain) Dual Pathology and alcoholism: Therapeutic answers J. Solé (Spain)   S11 Duality in Bipolar Disorders: A reality obligatory to be understood Chair: J. M. Montes (Spain) Speakers: Clinical importance of a dual diagnosis in bipolar disorders J.M. Goikolea (Spain) Psychopharmacological treatment of bipolar disorders with comorbidity with toxic abuse A. Benabarre (Spain) Psychosocial approaches in dual diagnosis in bipolar patients M. Mas-Baga (Spain) Role of Dopamine in the Compensating system and attribution to reality: understanding dual Pathology G. Lahera (Spain) S12 Dopamine: Dual pathology and depression        (Organized by GlaxoSmithKline) Chair: M. Casas (Spain) Speakers: Neurobiology in dopamine-energetic circuits in affective disorders with substance abuse and dependency M. Farré (Spain) Clinical aspects of dual pathology in depression: C. Roncero (Spain) Therapeutic implications Mª D. Franco (Spain) S13 Dual Pathology as a Risk Factor  Chair: G. Rubio-Valladolid (Spain) Speakers: Patients with dual diagnosis: A new challenge in psychiatric emergencies M. Aragües (Spain) Damaged cogniction: Cause or consequence in patients with schizophrenia and substance abuse diagnosis? R. Rodríguez-Jiménez (Spain) Impulsivity as a common element in disorders due to substance abuse or other psychiatric disorders M. Navío (Spain) Addictive habits and psychiatric comorbidity in advanced age L. Agüera (Spain)   S14 The Homeless and Dual Pathology        (Organized by Madrid Salud) Chair: F. Babin-Vich (Spain) Speakers: Tackling rough sleeping in England S.Guyon (United Kingdom) and J.Espinera (United Kingdom) Tackling of Homeless which present Dual Pathology, from the Municipal Network, in the city of Madrid D.Pérez-Madera (Spain) Tackling Dual Pathology on Homeless people in the city of Madrid. Experiences from the drug-dependants care centres of the Municipal Network A.Cáceres (Spain) S15 Legal Psychiatry and Dual Pathology Chair: Speakers: A. Calcedo-Ordoñez (Spain) Dual Pathology within prisons V. Tort (Spain) Community medical- legal problems in the attention to drugdependents J. Sanz (Spain) The addict patient responsability facing his/her own addictive conduct A. Calcedo-Barba (Spain) S16 Stress, intake and reward system Chair: A. Charro (Spain) Speakers: Energetical Haemoestasis and intake regulating mechanisms J.A. Cabranes and I. Ancín (Spain) Gene implication in stress bypasses and compensation in obesity A. Barabash and B. Vazquez (Spain) Morbid Obesity. Personality versus confronting strategies D. Jiménez, M. Sanz, M. Velao and B. Torres-Pardo (Spain) Repercussions of Bariatric Surgery in food disorders, impulsivity and psychiatric pathologies Associated to Morbid Obesity M. Saénz-Herrero and J. García-Albea (Spain) S17 Sick doctors and Dual Pathology Chair: C. Roncero (Spain) Speakers: Dual Pathology in hospitalized sick doctors P. Lusilla (Spain) Burnt out and drug dependencies in medical doctors B. de la Fuentes (Spain) External health clinics for sick doctors M. del Mar Sánchez (Spain) S18 Evaluation and assessment in Dual Pathology Chair: M. D. Franco (Spain) Speakers: Assessment of the nuclear symptoms of dependence: psychophysiological correlations of craving M. Jiménez (Spain) Devising an evaluation guide in Dual Pathology P. Sáiz (Spain) Specific instruments in Dual Pathology: Regarding the PRISM L. Díaz (Spain) Challenges in the assessment of Dual Pathology P. García-Portilla (Spain)   S19 Addiction and new technologies Chair: Speakers: F. Ferre-Navarrete (Spain) Study of the problematic use of new technologies in adolescents and young people in the city of Madrid F. Babin-Vich (Spain) Psychopathology of addiction in adolescents and behavioral consequences in adulthood J. San Sebastián-Cabasés (Spain) Methodological difficulties in the investigation of new addictions D. Fraguas-Herráez (Spain)   S20 Epidemiology, Dual Pathology and Disorders Due to Drug Intake Moderador: F.J. Álvarez (Spain) Ponentes: Dual Pathology in patients: Depending on substances and scenarios M. Torrens (Spain) y A. Domingo (Spain) Dual Pathology and adherence to treatment of patients with cannabis adictions B. Gonzalvo (Spain) y C. Roncero (Spain) Epidemiology in alcoholic dual pathologic patients A. LLigoña (Spain)   S21 Addictions and depressive disorders Chair: M. Torrens (Spain) Speakers: Contributions of the animal models to the study of the dual situation of depression-addiction O. Valverde (Spain) Epidemiological Aspects of Depression in addictions R. Martín-Santos (Spain) Pharmacological treatment of depression in addicted patients M. Torrens (Spain) Depression and substance use disorders in Primary Care: The diamond study G. Gilchrist (Australia) S22 Drug dependencies and Dual Pathology from an evolution perspective Chair: C. Álvarez-Vara (Spain) Speakers: Dual Pathology from an evolution perspective L. Caballero (Spain) Interaction genetics environment J. Sanjuan (Spain) S23 Eating Disorders (ET) and Dual Pathology Chair: M. Díaz-Marsá (Spain) Speakers: Update of Dual pathology disorder in TCA L. Rojo (Spain) Therapeutic trends in TCA with addictions F. Vaz (Spain) Gender differences in the development of TCA or toxic intake L. Beato (Spain) S24 Transcultural factors in Dual Pathology Chair: L. Caballero (Spain) Speakers: Cultural Formulae in Dual Pathology L. Caballero (Spain) Clinical management of immigrant Dual Pathology patients C. López (Spain) Profile of immigrant users within the Catalonian drugdependent network F. Collazos (Spain) S25 ADHD along the life-span and disorders due to the use of substances: Update        (Satelite symposium organized by Janssen Pharmaceuticals) Chair: M. Casas (Spain) Speakers: Disorders due to substance intake in a sample of Spanish adults with ADHD J. A. Ramos-Quiroga (Spain) ADHD in patients with Disorders due to substance intake C. Roncero (Spain) ADHD and Bipolar Disorders in childhood C. Soutullo (Spain) ADHD in adolescence and Disorders through substance intake J. Quintero (Spain) and J. A. Ramos-Quiroga (Spain)   S26 Dual Pathology in Geriatric Psychiatry Chairs: Speakers: A. Moriñigo (Spain) General context of Dual Pathology in Geriatric Psychiatry versus General Psychiatry S. Ros (Spain) Abuse of benzodiazepine in the elderly I.de la Serna (Spain) Alcoholism associated with other pathologies in Geriatric Psichiatry D. Franco (Spain) S27 Dual Pathology in Latinamerica: Asociación Latinoamericana de Adicciones    (ALAD) Chair: E. Velasquez (Colombia) Speakers: Bipolar Disorders and Addictions E. Velázquez (Colombia) Dual Pathology in the Ñaña Therapeutic Community R. Navarro-Cueva (Perú) Pathological Gambling and Dual Pathology C. Sanchez-Bello (Venezuela) Dual Pathology and Alcoholism in Ecuador S. Pacurucu (Ecuador) Depression and Tobacco J. Didia-Attas (Argentina) Comorbidity and treatment in tobacco addiction D. Seijas (Chile) Difficulties for comorbidity diagnosis in a modified Therapeutic Community R. Chandía (Chile)   S28 Addictions and impulse control. Unicity or Duality        (Symposium organized by the Spanish Society of Toxicomanias - SET) Chairs: Speakers: C. Puerta (Spain) and E. Ambrosio (Spain) Addiction and impulsivity: Introduction E.J.Pedrero-Pérez (Spain) Addiction and impulsivity from the frontal lobe operating perspective A. Verdejo-García (Spain) Addiction and impulsivity from a personality disorder perspective A. López-Durán (Spain) Cocaine addiction and attention deficit disorder (TDAH) from a spanish clinical sample J. Pérez-de los Cobos (Spain) and Grupo TDAH (Spain)  S29 Depression and Pain in Addictions               (Satelite symposium organized by Lilly Pharmaceuticals)  Chair: M. Roca (Spain)  Speakers: Depression, Anxiety and Pain in addictions. Neurobiological Aspects J. A. Micó (Spain) Depression, Anxiety and Pain in addictions. Clinical Aspects L. Caballero (Spain)  S30 Suboxone®: Progressing  in the treatment of opiate dependence         (Satelite symposium organized by Organon Schering- Plough Pharmaceuticals)  Chair: M. Casas (Spain)  Speakers: Pharmacological aspects of buprenorfina/naloxona programme treatments F. González- Saiz (Spain) Opium dependency treatments with Suboxone® C.Roncero (Spain) The European experience: France J. P Daulouede (France)    S31 Dual Patient in search of all inclusive intregal Treatment      Chair: M. Casas (Spain)  Speakers: Neurobiological bases of substance abuse. Why are they consumed? B.Álamo (Spain) Dual Pathology and Cocaine Treatment . New evidences G. Haro (Spain)    S32 Clinical pharmacological modalities for the treatment of dual bipolars Chair:                               E. Kalina (Argentina) Speakers:                         Integral approach to False Bipolars due to drugs                                         J. Aizpiri-Díaz (Spain)                                         Institutional control of the bipolar addict                                         P. M. Roig (Brasil)                                         Alcoholic bipolars                                         D.Kalina (Argentina)                                                                                 R. Chandía (Chile)       S33 Partial agonists in Dual Pathology: Aripiprazol, Buprenorfina, Vareniclina Chair: J.A. Micó (Spain) Speakers: Concept of parcial agonists J.A. Micó (Spain) Vareniclina E. Bruguera (Spain) Aripiprazol L. Caballero (Spain) Buprenorfina J. Ramírez (Spain)